When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SRNE - Sorrento in-licenses next-gen antibody-drug conjugate technology from Mayo Clinic
Sorrento Therapeutics Inc.
Sorrento Therapeutics (NASDAQ:SRNE) inks an agreement with Mayo Clinic securing exclusive rights to a technology platform that, it says, is capable of generating a great diversity of stable antibody-drug-nanoparticle albumin-bound (nab) immune complexes (ADNICs) targeting many types of human diseases including various solid and liquid tumors.
More news on: Sorrento Therapeutics, Inc., Healthcare stocks news,